Skip to main content

Abbott to invest €440 million in new facility in Kilkenny create 1,000 new jobs at Donegal site

Abbott to invest €440 million in new facility in Kilkenny create 1,000 new jobs at Donegal site

Friday, 12th August 2022 - IDA Ireland, together with Taoiseach Micheal Martin and Tánaiste Leo Varadkar, today welcomed news that leading global healthcare company Abbott is to construct a new greenfield manufacturing facility in Kilkenny and further invest in its Donegal Diabetes Care site, representing a combined investment of €440 million and creating 1,000 jobs between the two sites. 

The project is supported by the Irish Government through IDA Ireland. 

The new 250,000 sq. ft. state-of-the-art manufacturing facility, which will be located on the IDA Business and Technology Park in Loughboy, Kilkenny, subject to planning permission, will give Abbott the capacity to substantially increase production of its FreeStyle Libre technology for people with diabetes. 

Speaking about today’s announcement, Taoiseach Micheal Martin said: “This new investment by Abbott in Donegal and Kilkenny is hugely welcome news, bringing up to 1,000 highly-skilled jobs and expanded Medtech manufacturing capacity.

Abbott has a long and successful history, first establishing operations in Ireland in 1946, and this new investment is a great vote of confidence in the workforce here, and in this country as a place to invest. I wish all the team at Abbott every continued success in its endeavours in the years to come.”

Tanaiste and Minister for Enterprise, Trade and Employment Leo Varadkar said: “This is really fantastic news from Abbott. It’s a real vote of confidence in Kilkenny and Donegal and what those counties have to offer. We are working hard every day to create job opportunities in every county in the country, investing in every region to create a welcoming environment for the kind of opportunities we are seeing here today. It’s a major priority of mine as Minister for Enterprise, Trade and Employment. These 1,000 new jobs are a huge boost and really speak to the strength of Abbott’s 5,000 existing staff here. We never take this investment for granted. Thank you to the Abbott team.”

IDA Ireland Executive Director Mary Buckley said: “Abbott has had a longstanding presence in Ireland spanning over 75 years during which the company has made a substantial and valued contribution to regional economies. This significant and transformative investment in a new greenfield manufacturing facility in Kilkenny is fantastic news for the South East Region and for Ireland. It is also most welcome and demonstrates continued commitment to its Donegal site that it will benefit from further investment and new jobs as part of this investment and jobs announcement.  IDA Ireland’s strategy to win investment for regional locations across Ireland includes encouraging and supporting established companies to develop additional regional sites and this is a prime example of that. This new manufacturing facility will deliver a substantial boost to the economy of the South East. I wish the company continued success.”

You Might Also Be Interested In

  • 4 minute read
  • Published 18/11/2024

Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony attended by An Taoiseach, Simon Harris, TD, and Abbott Chairman and Chief Executive Officer, Robert Ford. The site is a global manufacturing centre of excellence for Abbott’s diabetes care business and will employ more than 800 people. 

Read more
  • 4 minute read
  • Published 07/11/2024

Freudenberg Medical opens expanded facility in Co. Leitrim and announces 250 new jobs

Freudenberg Medical, a leading global design, development and manufacturing partner for minimally invasive medical devices, has announced the creation of 250 new jobs, at the official opening of its newly expanded facility in Carrick-on-Shannon, Co. Leitrim, Ireland. 

Read more
  • 5 minute read
  • Published 20/09/2024

Integer Completes Two Irish Facility Expansions to Support Growth, Strengthen Capabilities in Critical Medtech Region

Integer Holdings Corporation, a leading medical device contract development and manufacturing organization (CDMO), today formally announced the completion of its facility expansions in Ireland.

Read more